Andere Sprachen Walvax Biotechnology Co., Ltd.

Aktien

300142

CNE100000WN2

300142

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 26.04.2024			% 5 Tage	% 1. Jan.
14,33 ^CNY	+3,54 %		+2,43 %	-39,05 %

26.04.	Gewinn von Walvax Biotechnology sinkt um 92%, Betriebsergebnis sinkt um 28% in Q1 2024	MT
25.04.	Einheit von Walvax Biotechnology beendet COVID-19-Impfstoffstudie	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024	26.04.
Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial	25.04.
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24.04.
China's drugmakers can't sell mRNA shots but haven't quit yet	19.04.
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03.04.
Walvax Biotechnology Co., Ltd.'s Equity Buyback announced on April 5, 2023, has expired with 2,000,000 shares, representing 0.12% for CNY 72.2 million.	03.04.
Walvax Biotechnology's 2023 Profit Falls 42%	02.04.
Walvax Biotechnology Co., Ltd. Proposes Cash Profit Distribution for 2023	01.04.
Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	01.04.
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26.03.
Walvax Biotechnology Sees Up to 45% Drop in 2023 Profit	26.01.
Chinese Shares End Mixed as Stimulus Hopes Fade; Walvax Falls 6% on Downbeat Profit Outlook	26.01.
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11.01.
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03.01.
Lanvin Group Chief Executive Joann Cheng Steps Down	08.12.
Walvax Biotechnology Registers Pneumonia Vaccines in Philippines	08.11.
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Walvax Biotechnology's Unit Gets License to Market Pneumonia Vaccine in Indonesia; Shares Up 3%	24.10.23
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	11.10.23
Walvax Biotechnology Unit Gets Nod to Carry Out Vaccine's Phase III Trial in Indonesia	20.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Walvax Biotechnology Co., Ltd.

Aktien

300142

CNE100000WN2

300142

Andere Sprachen

Filter